Aviva PLC Royalty Pharma PLC Transaction History
Aviva PLC
- $36.8 Billion
- Q4 2024
A detailed history of Aviva PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Aviva PLC holds 229,069 shares of RPRX stock, worth $7.25 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
229,069
Previous 14,123
1521.96%
Holding current value
$7.25 Million
Previous $399,000
1364.41%
% of portfolio
0.02%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RPRX
# of Institutions
433Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.25 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$729 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$537 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$447 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...